11/6
08:07 am
iova
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
Low
Report
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $32.00 price target on the stock.
10/24
07:31 am
iova
Rating for IOVA
Medium
Report
Rating for IOVA
10/24
07:16 am
iova
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $17.00 price target on the stock.
Medium
Report
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $17.00 price target on the stock.